25 March 2019 in Journal of the Endocrine Society
There is growing evidence that Autonomous Cortisol Secretion (ACS), previously known as Subclinical Cushing’s Syndrome is associated with greater prevalence of cardiovascular (CV) risk factors. It is, however, unclear if ACS is associated with increased CV outcomes compared with non-functioning adrenal adenomas (NFAA). The objective of this study is to evaluate 1) CV outcomes and 2) CV risk factors in adrenal adenoma patients with ACS versus NFAA. A literature review was performed using EMBASE, Medline, Cochrane Library and reference lists within selected articles. The study protocol was registered with PROSPERO. A literature search yielded 6 studies that met the inclusion criteria. Studies varied on their definitions of ACS and CV outcomes. Two retrospective longitudinal studies further demonstrated increased incidence of new CV events (ACS 16.7% vs NFAA 6.7%, p=0.04), and increased CV mortality in patients with ACS (ACS 22.6% vs 2.5%, p=0.02). The prevalence of CV outcomes in ACS was > 3 times greater than in patients with NFAA. Three of five studies found that ACS was associated with higher prevalence of DM and HTN. There was no difference in dyslipidemia or BMI demonstrated in any study. There is significant heterogeneity among the few studies evaluating the association between ACS and CV outcomes. While these studies suggest an increased risk of CV outcomes in patients with ACS, many did not adjust for known confounders. Larger, high quality, prospective studies are needed to evaluate this association and to identify modifiable risk factors.